Q-Switched Nd:YAG in Macular Amyloidosis

Shahid Beheshti University of Medical Sciences20 enrolled

Overview

The purpose of this study is to determine whether Q-Switched Nd:YAG Laser therapy are effective in reduction of Cutaneous macular amyloidosis.

We treat the macular amyloidosis cases by Q-Switched Nd:YAG Laser and compare the before and after treatment situation by the photos and colorimetric assessment.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Macular Amyloidosis

Interventions

Laser TherapyDEVICE

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Macular amyloidosis confirmed cases Exclusion Criteria: * Pregnancy and breast feeding * Over 18 years old

Locations (1)

Skin Research Center, Shaheed Beheshti Medical University

Tehran, Iran

Outcomes

Primary Outcomes

Visual and colorimetric assessment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.